Motley Fool Money cover image

Show Business is Back in Business!

Motley Fool Money

Eli Lilly's Zepbound and the Potential Impact of Weight Loss Drugs

4min Snip

00:00
Play full episode
The hosts discuss the FDA approval of a weight loss drug and its impact on Eli Lilly and the weight loss market, including expectations and skepticism surrounding these drugs.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode